DJIA 17,596.35 -350.33 -1.95%
NASDAQ 4,958.47 -122.04 -2.40%
S&P 500 2,057.64 -43.85 -2.09%
market minute promo

Pfizer (NYSE: PFE)

33.59 -0.33 (-0.97%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $33.59 -0.97%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.73
Previous Close $33.92
Daily Range $33.54 - $34.12
52-Week Range $27.51 - $35.53
Market Cap $206.8B
P/E Ratio 23.56
Dividend (Yield) $1.12 (3.3%)
Ex-Dividend Date
Dividend Pay Date
08/05/15
09/02/15
Volume 28,838,860
Average Daily Volume 21,978,876
Current FY EPS $2.03

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

What Is Carl Icahn's Net Worth?

A look at the billionaire activist investor and hedge-fund manager, including some cautionary tales.

Despite Recent Downgrade, This Ecommerce Giant is a Buy

Dow Movers: JPM, PFE

Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Zoetis Merger Rumors

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis Merger Rumors

Dow 30 Stock Roundup: Nike Beats Estimates, Verizon Closes AOL Buy - Analyst Blog

Zoetis Up as Valeant Rumored to be Interested in Buyout - Analyst Blog

Is Big Pharma Advertising Getting Out of Control?

Premarket Biotech Digest: Valent May Buy Zoetis, Medicines Co.'s Kengreal Approval, 2 New BMY Trials

Premarket Biotech Digest: Valent May Buy Zoetis, Medicines Co.'s Kengreal Approval, 2 New BMY Trials, Glaukos Jumps 70% Post IPO

Are value stocks the next Brooklyn?

See More PFE News...

PFE's Top Competitors

PFE $33.59 (-0.97%)
Current stock: PFE
JNJ $97.68 (-1.97%)
Current stock: JNJ
ROG $66.41 (-2.54%)
Current stock: ROG
GSK $42.03 (-2.01%)
Current stock: GSK